AbCellera Biologics (ABCL)
(Real Time Quote from BATS)
$2.80 USD
+0.01 (0.36%)
Updated Jun 27, 2024 02:12 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
AbCellera Biologics Inc. [ABCL]
Reports for Purchase
Showing records 1 - 19 ( 19 total )
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Digital Biology Tech- Enabled Drug Discovery Initiation
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
2Q-2023 Results : Slower pace of pertne, but long term Trajectory Remains on Track
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
1Q-2023 Revenues and Partnerships Light: Progress on Partnered Programs shows Platform potential
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
4Q-2022 Results-Light on Revenue, But Pipeline Momentum Builds.
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
FY-2021 Results Shifting focus to Program starts but Strategy Unchanged.
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
|